TBC1 domain family member 5 (TBC1D5) is a critical regulatory protein involved in the intricate processes of autophagy and endosomal trafficking. As a GTPase-activating protein (GAP) for Rab7, TBC1D5 plays a pivotal role in the modulation of Rab7 activity, which is essential for the late endosomal maturation, lysosome function, and the autophagic degradation pathway. The precise regulation of Rab7 activity by TBC1D5 ensures the proper delivery and degradation of cellular cargoes, thereby maintaining cellular homeostasis and responding to nutrient stress. TBC1D5's interaction with the retromer complex and its involvement in the recycling of transmembrane receptors highlight its significance in the sorting and trafficking processes that are fundamental to cell signaling and nutrient uptake. This protein's function is critical for the cellular response to environmental changes, playing a role in processes ranging from the downregulation of growth factor receptors to the clearance of damaged organelles through autophagy.
The inhibition of TBC1D5 can disrupt the delicate balance of endosomal trafficking and autophagy, leading to impaired cellular function and potentially contributing to the pathogenesis of various diseases. Inhibition can occur through several mechanisms, including post-translational modifications that alter TBC1D5's stability or its interaction with Rab7 and other proteins involved in membrane trafficking. Phosphorylation, ubiquitination, or other modifications of TBC1D5 could impact its localization, ability to bind Rab7, or its GAP activity, thereby affecting the dynamics of endosomal maturation and autophagosome formation. Furthermore, the expression levels of TBC1D5 may be regulated at the transcriptional or translational level, influenced by cellular stress signals or metabolic conditions. This regulation ensures that TBC1D5 activity is finely tuned to the cell's needs, with its inhibition potentially leading to the accumulation of dysfunctional organelles and impaired response to nutrient deprivation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine can disrupt microtubule dynamics, which are critical for the function of Rab GTPases, including Rab7. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3Ks), which are involved in autophagy regulation. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-MA is a PI3K inhibitor, similar to Wortmannin, and can block autophagy. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine inhibits lysosomal acidification, thereby impairing autophagy. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits vacuolar-type H+-ATPase, disrupting lysosomal function and autophagy. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
SAR405 is a specific and potent inhibitor of Vps34, a class III PI3K involved in autophagy. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1 promotes the degradation of certain PI3Ks, thus inhibiting autophagy. | ||||||
MHY1485 | 326914-06-1 | sc-507522 | 10 mg | $140.00 | ||
MHY1485 is an mTOR activator, and since mTOR negatively regulates autophagy, this compound can inhibit autophagy. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a GTPase inhibitor which can disrupt endocytic trafficking. | ||||||
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $104.00 | 20 | |
EIPA inhibits macropinocytosis, a form of endocytosis, affecting endocytic trafficking. | ||||||